0001104659-22-052533.txt : 20220428 0001104659-22-052533.hdr.sgml : 20220428 20220428182241 ACCESSION NUMBER: 0001104659-22-052533 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220426 FILED AS OF DATE: 20220428 DATE AS OF CHANGE: 20220428 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rajah Vignesh CENTRAL INDEX KEY: 0001815042 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38650 FILM NUMBER: 22868796 MAIL ADDRESS: STREET 1: HENRIKSHOJ 8 STREET 2: ROOM 4 CITY: VEDBAEK STATE: G7 ZIP: DK-2950 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc. CENTRAL INDEX KEY: 0001722964 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474619612 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 BUSINESS PHONE: 212-847-9841 MAIL ADDRESS: STREET 1: 230 PARK AVENUE STREET 2: SUITE 3350 CITY: NEW YORK STATE: NY ZIP: 10169 4 1 tm2213811-6_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-04-26 0 0001722964 Y-mAbs Therapeutics, Inc. YMAB 0001815042 Rajah Vignesh C/O Y-MABS THERAPEUTICS, INC. 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 0 1 0 0 SVP & CMO Employee Stock Option (right to buy) 9.51 2022-04-26 4 A 0 20000 0 A 2032-04-26 Common stock 20000 20000 D Stock options granted to the Reporting Person pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. The stock option shall vest and become exercisable as to 50% of the shares subject to the options on April 26, 2023 and as to the remaining 50% of the shares subject to the options on April 26, 2024, subject to the continuing employment of the Reporting Person on each vesting date. /s/ Vignesh Rajah 2022-04-28